Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system

被引：0
作者：
Lena Mahmoudi Azar
Elif Karaman
Burcu Beyaz
Işılay Göktan
Alp Ertunga Eyüpoğlu
Seda Kizilel
Batu Erman
Ahmet Gül
Serdar Uysal
机构：
[1] Beykoz Institute of Life Sciences and Biotechnology,Department of Molecular Pathobiology
[2] Bezmialem Vakif University,NYU Pain Research Center
[3] New York University College of Dentistry,Department of Biotechnology
[4] New York University College of Dentistry,Chemical and Biological Engineering
[5] Institute of Health Sciences,Department of of Molecular Biology and Genetics, Faculty of Arts and Sciences
[6] Bezmialem Vakif University,Department of Internal Medicine, Istanbul Faculty of Medicine
[7] Koç University,undefined
[8] Bogazici University,undefined
[9] Istanbul University,undefined
来源：
BMC Biotechnology | / 23卷
关键词：
Interleukin-1 receptor antagonist; Anakinra; IL-1Ra; Half-life; Surface plasmon resonance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 259 条
  • [1] Dinarello CA(1996)Biologic basis for interleukin-1 in disease Blood 87 2095-2147
  • [2] Garlanda C(2013)The interleukin-1 family: back to the future Immunity 39 1003-1018
  • [3] Dinarello CA(2019)Injectable biomaterials for delivery of interleukin-1 receptor antagonist: toward improving its therapeutic effect Acta Biomater 93 123-134
  • [4] Mantovani A(2000)The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1 N Engl J Med 343 732-734
  • [5] Clements AE(1990)Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor Nature 343 336-340
  • [6] Murphy WL(2004)Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention Nat Rev Drug Discovery 3 330-340
  • [7] Dinarello C(2003)Clinical and radiological effects of anakinra in patients with rheumatoid arthritis Rheumatology 42 22-28
  • [8] Hannum CH(2004)Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial J Rheumatol 31 1103-1111
  • [9] Wilcox CJ(2009)Anakinra for rheumatoid arthritis: a systematic review J Rheumatol 36 1118-1125
  • [10] Arend WP(2002)Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial Arthritis Rheumatism 46 2838-2846
12345678910